• Keine Ergebnisse gefunden

Biparental immune priming in the pipefish Syngnathus typhle – Supplementary Figures

N/A
N/A
Protected

Academic year: 2022

Aktie "Biparental immune priming in the pipefish Syngnathus typhle – Supplementary Figures"

Copied!
4
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

Biparental immune priming in the pipefish Syngnathus typhle – Supplementary Figures

Fig. S1. Experimental design to explore maternal, paternal and biparental immune priming effects and parental bacteria specificity in the pipefish Syngnathus typhle. In total seven parental treatment groups were set up, with each sex of the parents exposed either to a different bacterial strain or without any treatment: (1) control (both parents naïve); only maternal exposure to (2) Vibrio (MatV+) or (3) Tenacibaculum (MatT+); only paternal exposure to (4) Vibrio (PatV+) or (5) Tenacibaculum (PatT+); both parents exposed to different bacteria: (6) MatV+PatT+ and (7) MatT+PatV+. At 1 week and 4 months post birth, F1 offspring were exposed to the homologous or heterologous bacteria as their parents or received no challenge as controls. To test for uni-parental immune priming effects the parental treatment groups were pooled into the following four groups: 1. Control (naïve); 2. maternal (MatV+ and MatT+); 3. paternal (PatV+ and PatT+); 4. bi-parental (MatV+PatT+ and MatT+PatV+).

(2)

Fig. S2. Lymphocyte/monocyte ratio in head kidney of four-month-old juveniles (N = 126) grouped by F0-parents x F1-offspring interaction terms. Bar plot to visualize maternal and paternal bacteria specificity effects based on lymphocyte/monocyte ratio in the head kidney of four-month-old F1-juveniles. The first term of the annotation indicates the F0-parental treatment (parental control (Control), maternal Vibrio (MatV+) or Tenacibaculum (MatT+), paternal Vibrio (PatV+) or Tenacibaculum (PatT+), or bi-parental (Bi-(MatV+PatT+) / Bi-(MatT+PatV+)). The second term indicates the respective F1-offspring treatment (Vibrio (V+), Tenacibaculum (T+) and control (N). Error bars represent the standard error of the mean (+/-sem).

(3)

Fig. S3. Parental treatment effects based on life history parameters of one-week-old juveniles (N = 420) and four-month-old juveniles (N = 126). Bar plots are grouped according to F0-parental treatments (parental control (Control), maternal Vibrio (MatV+) or Tenacibaculum (MatT+), paternal Vibrio (PatV+) or Tenacibaculum (PatT+), biparental (Bi-(MatV+PatT+) or Bi-(MatT+PatV+)). Error bars represent the standard error of the mean (+/- sem). (A) size of one-week- old juveniles, (B) size of four-month-old juveniles, (C) mass (body weight) of four-month-old juveniles, (D) hepatosomatic index (HSI) of four-month-old juveniles.

Asterisks denote significant differences compared to the control group. The double asterisk in (A) denotes significant differences compared to the control group and the other treatment groups.

(4)

Fig. S4. Parental treatment effects on the time for F1-males to reach sexual-maturity (N = 170). Bar plot is grouped according to F0-parental treatments (parental control, maternal, paternal and biparental) and represents the time (days post birth) F1-males needed to create functional brood pouch tissue and reach sexual maturity. Error bars represent the standard error of the mean (+/-sem).

Abbildung

Fig.  S1.  Experimental  design  to  explore  maternal,  paternal  and  biparental  immune  priming  effects  and  parental  bacteria  specificity  in  the  pipefish  Syngnathus  typhle
Fig. S2. Lymphocyte/monocyte ratio in head kidney of four-month-old juveniles (N = 126) grouped by F0-parents x F1-offspring interaction terms
Fig.  S3.  Parental treatment  effects  based  on  life  history  parameters  of  one-week-old  juveniles  (N =  420)  and  four-month-old  juveniles  (N  =  126)
Fig.  S4.  Parental  treatment  effects  on  the  time  for  F1-males  to  reach  sexual-maturity  (N  =  170)

Referenzen

ÄHNLICHE DOKUMENTE

In that regard, the CJEU found that “the positions of a male and a female worker, father and mother of a young child, are comparable with regard to their possible need to

Pembrolizumab (KEYTRUDA®; Merck) is a highly selective humanized IgG4 monoclonal PD 1 receptor inhibitor approved as a first-line therapy for metastatic NSCLC with a PD-L1

Dengue morbidity can be reduced by implementing improved outbreak prediction and detection through coordinated epidemiological and entomological surveillance; promoting

(Quelle: Landesinstitut für Schulqualität und Lehrerbildung Sachsen-Anhalt (LISA), Niveaubestimmende Aufgaben zum Fachlehrplan Gymnasium Englisch). Audiodokument: Aufnahme

Although the strength of associations may vary, adolescents from all three cultures are expected to be more likely to choose helping parents with chores over going out with

This supports the “strain hypothesis.” A situation where parents and adult children have little reason to worry about financial and job se- curity and which allows young adults

Whilst possibly inoculation with live avirulent vaccine will prove of some value in the prevention of pneumonic plague, administration of prophylactic sulfa-doses has given

Subsequently, hypercapnic exposure was repeated under the addition of transport inhibitors, 5-(iV,N-dimethyl)- amiloride (DMA) for the inhibition of Na’/Hi-exchange